AlphaYouNTLA: Dube Michael P discloses a sale
By AlphaYouPublished Form 4
Dube Michael P
Reporting filer
Dube Michael P reported Sale in Intellia Therapeutics, Inc.: 1864 units of Common Stock, dated 2026-10-02. The full Form 4 contains 1 transaction entry.
- Disclosed
- Oct 6, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Dube Michael P | 2026-10-02 | S | Sale | 1864 | 12.43 | 65,022 | 4 days | Filed terms
|
Common Stock
- Owner
- Dube Michael P
- Date
- 2026-10-02
- Code
- S
- Action
- Sale
- Quantity
- 1864
- Price
- 12.43
- Following holdings
- 65,022
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-02
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 1864
- transaction Price Per Share: 12.43
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 65022
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Dube Michael P: VP, Chief Accounting Officer.
- F1: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on October 1, 2026, and does not represent a volitional trade by the Reporting Person.
Original sources
Prepared automatically from public filing data. Report a correction.